PINK

Simplify Health Care ETF

Spotlight Banner
as of 10/25/2021

NAV

$ 25.93

NAV Change

- $ 0.01 /0.04%

Price

$ 25.93

Price Change

- $ 0.01 /0.04%

The Simplify Health Care ETF (PINK) seeks long term capital appreciation by providing investors with multi-cap exposure to groundbreaking and innovative companies in biotech, medtech, gene therapy, and other fast growing health care related sectors.  

Michael Taylor serves as lead portfolio manager of the ETF and brings over two decades of experience managing long/short health care equity portfolios at leading hedge funds. PINK is the first 100% pro bono ETF focused on the health care sector and net profits will be donated for the benefit of the Susan G. Komen foundation on an annual basis.  

PINK: Shares for the Cure Find out more.

Benefiting Susan G. Komen logo

 

Spotlight Banner

Documents

View Research Tools

Fund Overview

As of 10/25/2021

Ticker Symbol
PINK
Gross Expense Ratio
0.50%
CUSIP
82889N772
Total Assets
$3,241,301.86
Shares Outstanding
125,001
Distribution Yield as of 10/25/2021
N/A
SEC 30-Day Yield as of 10/25/2021
—
Options Available
No
Inception Date
10/07/2021
Premium/Discount (%) as of 10/25/2021
0.00%
NAV
$25.93
NAV Per Share as of 10/25/2021
$25.93
Market Price as of 10/25/2021
$25.93
30-Day Median Bid-Ask Spread
N/A
Bid/Ask
$25.92/$25.96
Midpoint Price
$25.94
Volume
1,547
NAV Symbol
PINK.NV
IOPV Symbol
PINK.IV
Shares Out. Symbol
PINK.SO

Fund Performance

As of 09/30/2021 09/30/2021

Monthly Quarterly
Cumulative 1 Month 3 Month 6 Month 1 Year Since Inception
NAV — — — — —
Market Price — — — — —
Annualized 1 Year 3 Year Since Inception
NAV — — —
Market Price — — —
Cumulative 1 Year Since Inception
NAV — —
Market Price — —
Annualized 1 Year 3 Year 5 Year Since Inception
NAV — — — —
Market Price — — — —
The performance data quoted represents past performance and is no guarantee of future results. Current performance may be lower or higher than the performance data quoted. Investment returns and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Performance data for the most recent month-end is available above.

NAV: The dollar value of a single share, based on the value of the underlying assets of the fund minus its liabilities, divided by the number of shares outstanding. Calculated at the end of each business day.

Market Price: The current price at which shares are bought and sold. Market returns are based upon the last trade price.

Historical Premium/Discount

Calendar Year 2020 3rd Quarter of 2021
Days Traded at Premium N/A N/A
Days Traded at Discount N/A N/A
The above frequency distribution chart presents information about the difference between the daily market price for shares of the Fund and the Fund's reported Net Asset Value. The amount that the Fund's market price is above the reported NAV is called the premium. The amount that the Fund's market price is below the reported NAV is called the discount. The market price is determined using the midpoint between the highest bid and the lowest offer on the listing exchange, as of the time that the Fund's NAV is calculated (usually 4:00 p.m. EST). The horizontal axis of the chart shows the premium or discount expressed in basis points. The vertical axis indicates the number of trading days in the period covered by the chart. Each bar in the chart shows the number of trading days in which the Fund traded within the premium/discount range indicated.

Portfolio Holdings

As of 10/25/2021

Holdings - All ETFs
Ticker Name Quantity Weight
JNJ Johnson & Johnson 1765 8.93%
UNH United Health Group Inc. 614 8.51%
ABT Abbott Labs 1281 5.00%
DXCM DEXCOM INC USD 0.001 276 4.84%
MDT MEDTRONIC PLC 1216 4.64%
ZTS ZOETIS INC USD 0.01 645 4.21%
PODD INSULET CORP USD 0.001 390 3.64%
ANTM ANTHEM INC USD 0.01 255 3.42%
MRK MERCK & CO INC 1315 3.31%
LLY Lilly (Eli) & Co. 415 3.14%
HZNP HORIZON THERAPEUTICS PLC 840 3.01%
EW Edwards Lifesciences Corp. 735 2.66%
SYK Stryker Corp. 300 2.53%
ABBV ABBVIE INC USD 0.01 720 2.41%
AMGN Amgen 370 2.37%
TMO Thermo Fisher Scientific Inc 110 2.06%
BSX Boston Scientific Corp. 1475 2.02%
CVS CVS/Caremark Corp. 745 2.02%
DHR Danaher Corp. 210 1.98%
ZBH ZIMMER BIOMET HLDGS INC USD 0.01 425 1.98%
CERN Cerner Corp 890 1.97%
HCA HCA HLDGS INC USD 0.01 255 1.90%
HUM Humana Inc. 120 1.72%
CI Cigna Corp 235 1.56%
BDX Becton, Dickinson 195 1.48%
IQV IQVIA Holdings Inc 165 1.31%
GILD Gilead Sciences 580 1.21%
CRL Charles River Labs 80 1.05%
TECH BIO-TECHNE CORP 65 1.02%
WAT Waters Corporation 90 1.02%
A Agilent Technologies 205 1.00%
BAX Baxter International Inc. 390 0.98%
WST West Pharmaceutical Services Inc 75 0.97%
ALGN Align Technology Inc 50 0.91%
ISRG Intuitive Surgical Inc. 80 0.85%
LH Laboratory Corp. of America Holding 85 0.74%
MCK McKesson Corp. (New) 115 0.74%
BIIB BIOGEN IDEC Inc. 85 0.71%
VEEV Veeva Systems Inc 55 0.55%
CNC CENTENE CORP DEL 250 0.52%
VRTX Vertex Pharmaceuticals 90 0.51%
IDXX IDEXX Laboratories 25 0.50%
RMD ResMed Inc. 60 0.50%
ALNY Alnylam Pharmaceuticals Inc 80 0.49%
SGEN SEAGEN INC NPV 90 0.49%
STE STERIS PLC USD 75.0 40 0.29%
COO The Cooper Companies 20 0.26%
DGX Quest Diagnostics 55 0.25%
PKI PerkinElmer Inc 45 0.25%
HSIC Schein (Henry) Inc. 100 0.24%
MTD Mettler-Toledo Intl 5 0.23%
- Estimated Cash 36596 1.13%

Holdings are subject to change without notice.